The biological hallmarks of ileal carcinoids (Q28238359)

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02537.X

Comparative genomic hybridization identifies loss of 18q22-qter as an early and specific event in tumorigenesis of midgut carcinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02537.X

Tachykinins in endocrine tumors and the carcinoid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02537.X

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: biotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02537.X

Nordic Guidelines 2010 for diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02537.X

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02537.X

p27: a potential main inhibitor of cell proliferation in digestive endocrine tumors but not a marker of benign behavior.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02537.X

Morphological-histochemical study of intestinal carcinoids and K-ras mutation analysis in appendiceal carcinoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02537.X

Genetic alterations in poorly differentiated endocrine carcinomas of the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02537.X

K-ras and p53 mutations in the pathogenesis of classical and goblet cell carcinoids of the appendix

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02537.X

Autocrine growth inhibition by transforming growth factor beta-1 (TGFbeta-1) in human neuroendocrine tumour cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02537.X

Small bowel carcinoid (enterochromaffin cell) neoplasia exhibits transforming growth factor-beta1-mediated regulatory abnormalities including up-regulation of C-Myc and MTA1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02537.X

Epidermal growth factor receptor expression and activation in neuroendocrine tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02537.X

Amyloid precursor-like protein 1 is differentially upregulated in neuroendocrine tumours of the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02537.X

Hairy Enhancer of Split-1 (HES-1), a Notch1 effector, inhibits the growth of carcinoid tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02537.X

Hoxc6 is overexpressed in gastrointestinal carcinoids and interacts with JunD to regulate tumor growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02537.X

Loss of HOXC6 expression induces apoptosis in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02537.X

Activity of sunitinib in patients with advanced neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02537.X

Mutations in the MEN I gene in sporadic neuroendocrine tumours of gastroenteropancreatic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02537.X

Mutations and allelic deletions of the MEN1 gene are associated with a subset of sporadic endocrine pancreatic and neuroendocrine tumors and not restricted to foregut neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02537.X

Altered serotonin physiology in human breast cancers favors paradoxical growth and cell survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02537.X

Gene expression in midgut carcinoid tumors: potential targets for immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02537.X

Receptor‐mediated autocrine growth‐stimulatory effect of 5‐hydroxytryptamine on cultured human pancreatic carcinoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02537.X

The 5-HT(2B) receptor plays a key regulatory role in both neuroendocrine tumor cell proliferation and the modulation of the fibroblast component of the neoplastic microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02537.X

Growth factor receptor expression in human gastroenteropancreatic neuroendocrine tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02537.X

mRNA expression patterns of insulin-like growth factor system components in human neuroendocrine tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02537.X

Growth factors and carcinoid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02537.X

The role of beta-catenin, TGF beta 3, NGF2, FGF2, IGFR2, and BMP4 in the pathogenesis of mesenteric sclerosis and angiopathy in midgut carcinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02537.X

The effect of transforming growth factor beta on human neuroendocrine tumor BON cell proliferation and differentiation is mediated through somatostatin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02537.X

Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02537.X

Compensatory activation of Akt in response to mTOR and Raf inhibitors - a rationale for dual-targeted therapy approaches in neuroendocrine tumor disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02537.X

The somatostatin analogue octreotide confers sensitivity to rapamycin treatment on pituitary tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02537.X

Vascular endothelial growth factors, angiogenesis, and survival in human ileal enterochromaffin cell carcinoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02537.X

Fibrosis and carcinoid syndrome: from causation to future therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02537.X

The gastrointestinal tract stem cell niche

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02537.X

Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02537.X

Connective tissue growth factor expression in endocrine tumors is associated with high stromal expression of alpha-smooth muscle actin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02537.X

Nuclear translocation of beta-catenin protein but absence of beta-catenin and APC mutation in gastrointestinal carcinoid tumor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02537.X

Association of DNA methylation and epigenetic inactivation of RASSF1A and beta-catenin with metastasis in small bowel carcinoid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02537.X

CTGF mediates TGF-beta-induced fibronectin matrix deposition by upregulating active alpha5beta1 integrin in human mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02537.X

Connective tissue growth factor (CTGF/CCN2) in hepatic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02537.X

TGFbeta stimulated re-epithelialisation is regulated by CTGF and Ras/MEK/ERK signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02537.X

Role of ERK1/2 and PI3-K in the regulation of CTGF-induced ILK expression in HK-2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02537.X

CTGF, intestinal stellate cells and carcinoid fibrogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02537.X

Purification and characterization of novel heparin-binding growth factors in uterine secretory fluids. Identification as heparin-regulated Mr 10,000 forms of connective tissue growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02537.X

Induction of Apoptosis in Neuroendocrine Tumors of the Digestive System During Treatment with Somatostatin Analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02537.X

High-dose treatment with a long-acting somatostatin analogue in patients with advanced midgut carcinoid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02537.X

Connective tissue growth factor (CTGF) promotes activated mesangial cell survival via up-regulation of mitogen-activated protein kinase phosphatase-1 (MKP-1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02537.X

Predicting neuroendocrine tumor (carcinoid) neoplasia using gene expression profiling and supervised machine learning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02537.X

Senescence-associated beta-galactosidase is lysosomal beta-galactosidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02537.X

Hallmarks of senescence in carcinogenesis and cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02537.X

Microsatellite instability and mismatch repair gene inactivation in sporadic pancreatic and colon tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02537.X

Novel markers for enterochromaffin cells and gastrointestinal neuroendocrine carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02537.X

Modulation of CXCL14 (BRAK) expression in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02537.X

BRAK/CXCL14 expression suppresses tumor growth in vivo in human oral carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02537.X

MicroRNA expression in ileal carcinoid tumors: downregulation of microRNA-133a with tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02537.X

miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02537.X

Expression of connective tissue growth factor and IGF1 in normal and neoplastic gastrointestinal neuroendocrine cells and their clinico-pathological significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02537.X